Pre-gestational versus gestational diabetes: A population based study on clinical and demographic differences☆
Introduction
Diabetes complicates approximately 6%–7% of pregnancies in the United States, with California demonstrating a similar prevalence of 7.6% (Lawrence, Contreras, Chen, & Sacks, 2008). Approximately 85% are attributed to gestational diabetes mellitus (GDM), while the remaining are due to pre-gestational diabetes mellitus (PGDM) (Wier, Witt, Burgess, & Elixhauser, 2006).
GDM is currently defined by the American Diabetes Association as “any degree of glucose intolerance with onset or first recognition during pregnancy”(Diagnosis & classification of diabetes mellitus, 2012). The pathogenesis is typically attributed to insulin resistance during pregnancy due to factors such as human placental lactogen and tumor necrosis factor alpha (Metzger et al., 2008, Vambergue et al., 2002). PGDM, on the other hand, includes both type I and type 2 diabetes mellitus (DM) occurring prior to pregnancy.
Previous studies have reported on morbidities of both PGDM and GDM in pregnancy which include fetal macrosomia, neonatal hypoglycemia, perinatal mortality, polyhydramnios, and increased risk of cesarean delivery (American Diabetes Association, (2004), Macintosh et al., 2006, Persson et al., 2009). However, few studies have looked at direct comparisons of morbidity between subjects with PGDM and GDM. Given PGDM’s ability to affect the maternal–fetal dyad at an earlier gestational age, we hypothesize that there will be increased morbidity of PGDM when compared to GDM in all periods of pregnancy (pre-pregnancy, antepartum, and delivery). We also postulate that there will be certain racial predilections towards developing GDM and PGDM. We hypothesize that our results will confirm advancing maternal age to be associated with an increased risk of both conditions. Finally, we believe that incidences of both diseases have increased over time.
The objective of this study was to compare the trends, demographic factors and maternal morbidity between women with GDM versus those with PGDM using a California population cohort.
Section snippets
Patients and methods
This is a retrospective study using health discharge data for all deliveries during 2001–2007 in California. The dataset, provided by the California Office of Statewide Health Planning and Development (OSHPD), is a publicly available dataset comprising cases where a patient is treated in a licensed general acute care hospital in California. Information regarding demographics, diagnoses, specific procedures undergone, and details regarding the patient’s stay, such as source of funding, length of
Results
The prevalence of GDM was 5.34% while PGDM prevalence was 0.82% during the study period. As seen in Fig. 2, both conditions increased over time, even after age adjustment. PGDM increased from 0.69% in 2001 to 0.86% in 2007. GDM increased from 4.40% in 2001 to 6.41% in 2007. The mean maternal age of the entire study population was 31.14 ± 5.71 years standard deviation (SD), with 33.82% of all subjects being of advanced maternal age (age > 35 years).
The baseline characteristics for the 169,428 diabetic
Discussion
Our results demonstrate that both PGDM and GDM differ in several aspects — age distribution, race/ethnicity, and associations with clinical morbidities. Both diseases have increased over time, highlighting the need to investigate possible population-based clinical and demographic interactions.
Our study, to our knowledge, is the first to investigate the increased morbidity of PGDM compared to GDM using a large population. El Mallah et al. described that GDM and PGDM were similar in maternal,
References (30)
- et al.
Advanced maternal age and adverse perinatal outcome: A review of the evidence
Midwifery
(2011) - et al.
Gestational and pre-gestational diabetes: Comparison of maternal and fetal characteristics and outcome
International Journal Of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics
(1997) - et al.
Is the evidence strong enough to change the diagnostic criteria for gestational diabetes now?
American Journal of Obstetrics and Gynecology
(2013) - et al.
Accuracy of obstetric diagnoses and procedures in hospital discharge data
American Journal of Obstetrics and Gynecology
(2006 Apr) American Diabetes Association. (2004). Gestational diabetes mellitus
Diabetes Care
(2004)- et al.
Race/ethnicity and other risk factors for gestational diabetes
American Journal of Epidemiology
(1992) - et al.
Maternal and paternal race/ethnicity are both associated with gestational diabetes
American Journal of Obstetrics and Gynecology
(2010) National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States
- et al.
Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999–2002
Diabetes Care
(2006) - et al.
Increased incidence of glucose disorders during pregnancy is not explained by pre-pregnancy obesity in London, Canada
BMC Pregnancy and Childbirth
(2010)
When can odds ratios mislead?
BMJ
Diagnosis and classification of diabetes mellitus
Diabetes Care
Increasing prevalence of gestational diabetes mellitus: A public health perspective
Diabetes Care
ICD-9-CM: International classification of diseases, 9th revision; clinical modification, 6th edition/ Practice Management Information Corporation (PMIC)
Diabetes in pregnancy among Sri Lankan women: Gestational or pre-gestational?
Sri Lanka Journal of Diabetes Endocrinology and Metabolism
Cited by (0)
- ☆
The authors report no conflict of interest.